ST32
帕金森病活性和抗震颤作用。ST 1535 具有帕金森病研究的潜力。研究领域:GPCR/G Protein作用靶点:Adenosine ReceptorIn Vitro: ST 1535 (0-1000 nM) inhibits forskolin
ST使用机型:溶出仪包装规格:数量1
ST
with ~40% inhibition of dimerization at 5 μM ST2825 and 80% inhibition at 10 μM ST2825. In Vivo: ST2825 dose-dependently
agonist-induced cAMP accumulation with an IC50 value of 450 nM. In Vivo: ST3932 (10, 20, 40 mg/kg, p.o.) antagonizes
agonist-induced cAMP accumulation with an IC50 of 990 nM. In Vivo: ST4206 (10, 20, and 40 mg/kg, p.o.) antagonizes
As ST B
ST D
ST E
祝贺!第十五届光华工程科技奖获奖名单公布,这41名专家获奖
创新引领未来 | 安捷伦智能化气相色谱新品重磅发布
安捷伦在ASMS:智能推动性能 挑战极限应用
咨询热线: 010-84839035
联系邮箱: sales@antpedia.net